Related Experiment Video

Updated: Aug 6, 2026

Comparative Strategies for Ubiquitination Detection in Mammalian Cell Lysates Using SMAD2/SMURF2 as a Model
09:00

Comparative Strategies for Ubiquitination Detection in Mammalian Cell Lysates Using SMAD2/SMURF2 as a Model

Published on: April 17, 2026

Acute myelogenous leukemia-derived SMAD4 mutations target the protein to ubiquitin-proteasome degradation

Lei Yang1, Ning Wang, Yi Tang

  • 1School of Medicine, Shihezi University, Shihezi, Xinjiang, People's Republic of China.

Human Mutation
|July 26, 2006
PubMed

Insights

Mutated SMAD4 proteins in acute myelogenous leukemia are rapidly degraded through ubiquitination mediated by the SCF(beta-TrCP1) E3 ligase. This process targets tumor suppressor Smad4 for proteasomal degradation, contributing to TGF-beta signaling disruption.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Transforming growth factor-beta (TGF-beta) signaling disruption is implicated in hematological malignancies.
  • Smad4 is a crucial tumor suppressor in the TGF-beta pathway, and its mutations are found in cancers.
  • The mechanism of rapid degradation for mutated Smad4 proteins, particularly in acute myelogenous leukemia (AML), is not fully understood.

Purpose of the Study:

  • To investigate the protein stability of SMAD4 mutants identified in acute myelogenous leukemia.
  • To elucidate the degradation pathway of these mutated SMAD4 proteins.
  • To determine the role of beta-transducin-repeat-containing protein 1 (beta-TrCP1) in SMAD4 mutant degradation.

Main Methods:

  • Comparison of degradation rates between wild-type and mutant SMAD4 proteins.
  • Assessment of polyubiquitination and proteasomal degradation of SMAD4 mutants.
  • Co-immunoprecipitation assays to study the interaction between SMAD4 mutants and beta-TrCP1.
  • siRNA-mediated knockdown of beta-TrCP1 to observe its effect on SMAD4 mutant protein levels.

Main Results:

  • Two AML-derived SMAD4 mutants (Pro102Leu and Delta483-552) showed significantly faster degradation than wild-type SMAD4.
  • Both mutants exhibited increased polyubiquitination and were degraded via the proteasome.
  • beta-TrCP1 was identified as a key interacting protein that targets these SMAD4 mutants for degradation.
  • Suppression of beta-TrCP1 using siRNA led to increased protein levels of both overexpressed and endogenous SMAD4 mutants in AML cells.

Conclusions:

  • Mutated SMAD4 proteins in AML undergo rapid degradation mediated by the SCF(beta-TrCP1) E3 ligase complex.
  • This SCF(beta-TrCP1)-dependent ubiquitination and proteasomal degradation contributes to TGF-beta signaling disruption in AML.
  • Targeting the SCF(beta-TrCP1) pathway may offer therapeutic strategies for AML with SMAD4 mutations.

More Related Videos

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs10:44

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype14:51

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Published on: June 17, 2022

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...